等待開盤 03-26 09:30:00 美东时间
+0.360
+2.67%
Dow futures down 0.2%. Hesai Group -ADR shares drop 6.6% after reporting lower quarterly earnings and sales. Other stocks also down in pre-market.
03-24 20:02
BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it has completed a $1 million
03-19 19:37
今日重点评级关注:Freedom Capital Markets:维持LifeMD"买入"评级,目标价从8美元升至10美元;Chardan Capital:维持Opus Genetics"买入"评级,目标价从9美元升至11美元
03-13 09:59
Top analysts change outlook on top names. HC Wainwright cut BWAY price target, Mizuho raised PENN target, Telsey slashed SFIX target, BTIG cut AVAV target, Barrington cut CURI target, Morgan Stanley raised HON target, Stifel cut CPB target, Wells Fargo raised MU target.
03-12 21:28
HC Wainwright & Co. analyst Raghuram Selvaraju maintains BrainsWay (NASDAQ:BWAY) with a Buy and lowers the price target from $30 to $15.
03-12 20:20
BrainsWay Ltd. (NASDAQ:BWAY) reported fourth-quarter financial results on Wednesday ahead of the market open.
03-11 21:18
BrainsWay (NASDAQ:BWAY) sees FY2026 sales of $51.000 million-$52.000 million vs $64.986 million analyst estimate.
03-11 19:32
BrainsWay (NASDAQ:BWAY) reported quarterly earnings of $0.04 per share which met the analyst consensus estimate. This is a 75 percent increase over earnings of $0.02 per share from the same period last year. The company
03-11 19:31
Companies Reporting Before The Bell • Sprinklr (NYSE:CXM) is estimated to repor...
03-11 19:11
BrainsWay (NASDAQ:BWAY) is gearing up to announce its quarterly earnings on Wed...
03-11 02:01